BioMed 21 is a bold Washington University initiative dedicated to translating basic science discoveries into solutions for the world's biggest health problems.
Through its Interdisciplinary Research Centers (IRCs) and Cornerstone Centers, BioMed 21 promotes collaborative, strategically targeted basic science.
LEARN ABOUT CORNERSTONES
LEARN ABOUT IRCs
BioMed 21 takes aim at the world's most important diseases.
LEARN MORE ABOUT BIOMED 21
Cancer and Personalized Medicine
Diabetes, Heart Disease and Obesity
Infectious Diseases and Global Health
Women's and Children's Health
BioMed 21 scientists seek to understand and address underlying processes of brain injury and disease. The ultimate goal: Find ways to diagnose early, treat effectively, and in some cases, prevent altogether. Among the targets: Alzheimer's disease, ALS, brain trauma, epilepsy, stroke and depression.
The BRIGHT Institute
Center for Genome Sciences & Systems Biology
Center for the Investigation of Membrane Excitability Diseases
Center for Study of Itch
Center for Women's Infectious Disease Research
Diabetic Cardiovascular Disease Center
Hope Center Program on Protein Aggregation and Neurodegeneration
Center for Clinical Imaging
The Genome Institute
Institute of Clinical and Translational Sciences
September 23, 2012
September 17, 2012